The NIDA Avant-Garde Award Program for HIV/AIDS Research supports individual scientists of exceptional creativity who propose high-impact research that will open new areas of HIV/AIDS research relevant to drug abuse and/or lead to new avenues for prevention and treatment of HIV/AIDS among drug abusers. The term avant-garde is used to describe highly innovative approaches that have the potential to be transformative. The proposed research should reflect approaches and ideas that are substantially different from those already being pursued by the investigator or others and should support the NIH HIV/AIDS Research Priorities https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-018.html. The NIDA Avant-Garde award supports innovative, basic research that may lead to improved preventive interventions or therapies; creative, new strategies to prevent disease transmission; novel approaches to improve disease outcomes; and creative approaches to eradicating HIV or improving the lives of those living with HIV.
NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional)
Funding Organization:
The US Department of Health and Human Services National Institutes of Health
Funding Category:
HIV/AIDS
Other Health-Related
Support Types:
Discretionary Grants
Locations:
International
Eligible Organizations:
Maximum Amount:
$700,000
Fund ID:
PAR-23-269
Application Due Date:
Subjects:
Clinical Research
Data Analysis
Health Care Planning
Health Care Programs/Services
HIV
HIV and AIDS Prevention
Medical Treatments and Therapies
Research
Audiences:
At Risk Persons
Community Based Organizations
Health Professionals
Health Services Organizations
People who inject drugs
Persons with HIV/AIDS
Researchers
People with substance use disorder
Last Updated: